Scientists are developing a new pill-based Alzheimer’s treatment that targets a different pathway than the medications already on the market. Read about this and more top Alzheimer's headlines in our Breaking News Dispatch, supported by sponsorship funding from Lilly: https://bit.ly/41c8HfG.

Join us today as Dr. Michael Detke shares details about the SPRING trial studying an investigational oral drug aimed at reducing brain damage linked to the gum‑disease bacteria P. gingivalis. We'll also outline who may qualify & what participation looks like. youtube.com/live/y2o7wtfOSX8

In recognition of National Minority Health Month, Dr. Victoria Tseng joins Glaucoma Chats on April 8 to discuss the latest research on glaucoma disparities, cultural and healthcare barriers, and why early screening is critical to protecting vision. Register to ask your questions live. ↘️

#BreakingNews from #ADPD2026: New treatment approaches to address unmet needs for people living with Alzheimer’s. Read about promising data on a pill-based treatment, risk-reducing lifestyle changes effective a decade later, and other top stories: https://bit.ly/4bRwFSi

Join today’s episode of Zoom In on Dementia & Alzheimer’s to explore the early #Alzheimers symptoms to watch for, other medical issues that may look like dementia, and why early conversations with your doctor matter. Watch live at 1 p.m. today: https://www.youtube.com/live/LF1arJTrzes

Top questions from people living with macular degeneration will be answered live today at 1 p.m. ET! Join BrightFocus Foundation's #MacularChat for a real-time Q&A with ophthalmologist Dr. Joshua Dunaief. 🔗 Listen live now: BrightFocus.org/livechatMDR

We're hosting an interactive Macular Chat on March 25 where we'll answer your top questions about age-related macular degeneration (AMD). We’ll cover everything from the different types of AMD to nutrition, supplements, daily living tips, and treatment options. Register now: https://bit.ly/4rxnNHr

Look inside the hippocampus: where memories are made! The blue shows myelin, a protective coating on brain "wires" (axons) that speeds up messages between neurons. Dr. Isabelle Aubert is developing a therapy using noninvasive ultrasound waves that may boost myelin production. https://bit.ly/4rkP9Bk

Join Dr. Inas Aboobakar of Mass. Eye and Ear today, March 11 at 1pm ET, as she explains the role of genetics and family history in glaucoma as well as what and when to share with relatives, and how to encourage glaucoma eye exams. 🎧 Listen live: https://bit.ly/4nz3KGw

Join Dr. Inas Aboobakar of Mass. Eye and Ear today, March 11 at 1pm ET, as she explains the role of genetics and family history in glaucoma as well as what and when to share with relatives, and how to encourage glaucoma eye exams. 🎧 Listen live: https://bit.ly/4nz3KGw

On March 26, neurologist Dr. Sharon Cohen joins us to walk through the early signs of Alzheimer's, the conditions that can look like dementia but aren't, and how to have a productive conversation with your doctor. Bring your questions. Register to join live: https://bit.ly/4qhsHsO

In 2025, 182 clinical trials evaluated 138 experimental drugs, reflecting real momentum in how scientists understand the biology, genetics, and biomarkers driving this disease. Learn how that progress is translating into new ways to treat the disease. 🔴 WATCH LIVE TODAY: https://bit.ly/4aR3j7l

Family history is one of the strongest risk factors for glaucoma. Dr. Inas Aboobakar joins Glaucoma Chats to explain the role of genetics and family history in glaucoma, what and when to share with relatives, and how to encourage glaucoma eye exams. Register: https://bit.ly/4u7l1Lh

From disease-modifying therapies and oral pills to non-pharmacological options, the Alzheimer’s treatment pipeline includes a wider range of approaches than ever before. Read about what’s to come in 2026 and beyond: https://bit.ly/4aMpGcS.

Check out these stunning brain cells derived from a person with Alzheimer’s disease. • Green = Young • Red = Mature Dr. Josephy Herdy is using these stem cells to study how to stop brain inflammation in Alzheimer’s disease. Explore the research: https://bit.ly/3OqvJfz

Early-stage AMD often has no symptoms. By the time people notice vision changes, the disease may have already progressed. That's why Paul, a stand-up comedian living with AMD, recommends comprehensive eye exams for everyone over 40, even if your vision seems fine. https://bit.ly/49L8K7n.

🧬 LIVE today at 1 p.m. ET: Dr. Eric M. Reiman joins us to discuss APOE4, genetic testing, and what it means for your Alzheimer's risk. We'll also discuss treatments, potential side effects, and clinical research opportunities. Your questions welcome! ↘️ https://www.youtube.com/live/XDRd-MRpDRY

Could we prevent Alzheimer's before memory loss begins? Dr. Joshua Grill explains how researchers are exploring early treatment to slow or stop brain changes associated with Alzheimer’s disease in people at higher risk. Learn more about this promising area of research ➡️ https://bit.ly/4k3QPMP.

Age-related macular degeneration (AMD) is a leading cause of vision loss, yet many people don't know they have it until irreversible vision loss occurs. This #AMDAwarenessMonth, learn about the importance of regular eye exams, symptoms, risk factors & the latest research: https://bit.ly/4tzVDO1.

Reading a text message, recognizing a grandchild's face, navigating a familiar route: these ordinary acts rely on central vision. For nearly 20 million Americans, age-related macular degeneration puts all of that at risk. But early detection offers hope. Learn more: https://bit.ly/4bD2WOG.

Breaking News: On Feb 3, Congress passed, and the President signed into law, the Fiscal Year 2026 appropriations bill providing critical federal funding for the NIH, protecting brain and eye research. Read more. https://bit.ly/46qFBvV

You wouldn't skip your other wellness appointments—so why skip eye exams? Cynthia reminds us that protecting our vision deserves the same priority we give to other aspects of self-care. Watch her story. ⬇️ Get the facts about glaucoma this #GlaucomaAwarenessMonth: www.stopglaucoma.org

TOMORROW: Learn how retinal prostheses are designed to restore vision—not just slow its loss. Join us Wed, Jan 28 at 1 pm ET to explore the PRIMA implant and other breakthrough technologies currently in production. Watch live: https://bit.ly/4qJtjXX

CRISPR in action! The healthy cells (left) & disease-modified cells (right) create a 'mosaic' pattern, typical of gene editing. Dr. Brittany Carr, BrightFocus Foundation Macular Degeneration Research grantee, is using this technique to build more precise disease models. https://bit.ly/3YKpMMC

For decades, Alzheimer's drugs only treated symptoms. That's changed. Two FDA-approved therapies now target amyloid protein in the brain. But what does that mean for people living with the disease? Watch live: https://www.youtube.com/live/41AMx2fsdHM

Until recently, there were no Alzheimer's drugs that targeted the underlying causes of the disease. Now there are two. On Jan 22, hear from a leading neurologist about Leqembi and Kisunla—how they work, who's eligible, and what you need to know. Register: https://bit.ly/4qhsHsO

Glaucoma doesn’t just affect older adults. It can affect anyone at any age. Hillary explains why everyone, not just individuals with known risk factors, can benefit from regular eye exams to spot the earliest signs of glaucoma and other eye diseases. Learn more at: www.stopglaucoma.org

Join tomorrow's Glaucoma Chat with Dr. Mehul Nagarsheth, who will break down how early diagnosis opens the door to modern, less invasive treatment options. 🎧 Listen live tomorrow, Jan. 14 at 1 p.m. ET: https://bit.ly/4qFdiBH

Too many people see multiple specialists before receiving an Alzheimer’s diagnosis, losing precious time. BrightFocus Foundation supports the Alzheimer’s Policy Working Group’s initiative to provide actionable policy guidance to accelerate diagnosis and improve care. Read the report: alzpolicy.org

“I watched my grandfather’s sharp, witty mind fade away with dementia. That experience drives me to search for answers so other families don’t feel the same helplessness.” — Joe Herdy, PhD, BrightFocus Foundation Alzheimer's Disease Research grant recipient. Read more: https://bit.ly/4jAd4d1

Glaucoma treatment has come a long way. Register for our Jan. 14 Glaucoma Chat where Dr. Mehul Nagarsheth will break down how diagnosing glaucoma earlier gives you access to modern, less invasive treatments. 🔗 Register today and ask your questions live. https://bit.ly/3NyIYub

🧠 Why do some people stay sharp at 85 while others struggle at 76? The answer is "cognitive reserve," your brain's built-in resilience that can be strengthened through lifelong learning, physical activity, social connections, and proactive health management. Learn more: https://bit.ly/49nPMCf

The red cells are microglia—your eye's tiny defenders. 🛡️ These immune cells patrol the retina, protecting it from damage. Silvia Marinelli, PhD, a BrightFocus Foundation National Glaucoma Research grant recipient, is studying how we might harness them to fight vision loss. 🔬 https://bit.ly/4q6Ubkj

We're thrilled to announce that our Alzheimer's Fast Track 2025 workshop is being as the AARP Brain Health Action Collaborative Action of the Week! By connecting early-career scientists with leading experts, we’re igniting new ideas to advance Alzheimer's research: https://bit.ly/3MOcThQ.

🌍 Smart science knows no borders! BrightFocus Foundation is funding innovative research across 16 countries, supporting 186 projects that are advancing our understanding of Alzheimer's, macular degeneration, and glaucoma. Explore our 2025 research portfolios: https://bit.ly/4sa1OrC

🧠 Researchers have identified a promising new class of blood biomarkers known as circular RNAs (circRNAs) for early Alzheimer's detection. Read more : https://bit.ly/3N7zR3m

BrightFocus Foundation Alzheimer’s Disease Research grant recipient Dr. Hongjun Fu grows “mini-brains” to study why certain neurons are vulnerable in Alzheimer’s & PSP. These images show brain tissue at 60 days (left) and 120 days (right). Read more about Dr. Fu’s project: https://bit.ly/4s29wnt

The EVOKE trials found that semaglutide, the GLP-1 drug behind several popular diabetes and weight loss medications, did not meaningfully slow cognitive decline in people with Alzheimer’s disease. Explore this research and more news from #CTAD2025. https://bit.ly/48KgAxG

Did you know some people maintain sharp thinking skills even with Alzheimer's-related brain changes? Building cognitive reserve through lifelong learning, social connections, and healthy lifestyle choices may help protect your brain. Learn more: https://bit.ly/3MmMgAo

New study results indicate that lifestyle changes can protect aging brains. The U.S. POINTER study tested whether a structured, healthy lifestyle program could protect cognitive function in at-risk older adults. The answer is YES. Explore this news and more from #CTAD2025: https://bit.ly/4pTAgoa

🔬 $28.4 million. 🧠 111 projects. 🌍 13 countries. BrightFocus Foundation’s is funding bold ideas and cutting-edge research that could lead to ways to prevent, treat, and ultimately cure Alzheimer’s for the 7+ million Americans living with it. Explore the science: https://bit.ly/48HvKlM

Can Alzheimer's be stopped before it starts? The AHEAD Study is exploring that question. On Dec 18, Dr. Joshua Grill will explain how researchers are testing Leqembi in people at elevated risk for Alzheimer's—targeting brain changes years before symptoms emerge. Register now: https://bit.ly/4oEVZzm

A scientist funded by BrightFocus Foundation found a link between macular degeneration & Parkinson’s—a finding that led to the development of a new supplement to help protect sight. Now, he’s searching for new treatments that could benefit millions facing vision loss: https://bit.ly/4adXAsb.

The landscape of Alzheimer’s disease treatments is shifting. Dr. Marwan Sabbagh will join us to discuss the emerging therapies now in development—including disease-modifying drugs that target the underlying biology of Alzheimer’s. Join us TODAY at 1 pm ET: https://www.youtube.com/live/e_o2GsmiFTA

🚀 Exciting news! BrightFocus Foundation sponsored travel for 39 early-career scientists to attend @sfn.org's annual meeting in San Diego, and for many, it was their first time at the conference! 📸: A few of BrightFocus Foundation's travel grantees at #SfN2025.

In recognition of #NationalCaregiversMonth, our Nov Macular Chat will explore the role of caring for an individual with vision loss. Our guest experts will discuss the realities of caregiving, financial challenges, practical resources & support. 🎧 Tomorrow @ 1pm ET: BrightFocus.org/LiveChatMDR

💬✨🧠🌟Wrapping up an incredible Alzheimer’s Fast Track workshop! We’re truly inspired by the brilliant minds that gathered in San Diego to explore breakthrough ideas in Alzheimer's disease research. Exciting times ahead as we gear up for #SfN25! Special thanks to this year’s co-chairs and speakers!

Happening tomorrow: Get your glaucoma questions answered. Dr. Poonam Misra of Manhattan Eye, Ear & Throat Hospital joins our Glaucoma Chat at 1 p.m. ET for a live conversation. She’ll cover frequently asked questions about glaucoma. Listen live tomorrow: https://bit.ly/4nz3KGw

When Dave Palmer's father lost vision to age-related macular degeneration, Dave and his wife Leanna wanted to help. They started supporting Macular Degeneration Research at BrightFocus Foundation. See the impact of donor support in our 2025 annual report: https://bit.ly/4o6LuFF.

A surprising connection: Parkinson's drug L-DOPA protects against age-related macular degeneration (AMD). Researcher Brian McKay, PhD, used this finding to discover a protective eye pathway & create an AMD supplement. Now he's working on new treatments based on this discovery. 🔬